Ratings by Jones Trading (Boris Peaker)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2026 | CervoMed | CRVO | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2026 | Enliven Therapeutics | ELVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2026 | Elicio Therapeutics | ELTX | Downgrade | Hold (Buy) |
14.85 (1.56) |
-89.49% | Details | |
| 5/14/2026 | Adlai Nortye Ltd. | ANL | New Coverage | Buy (N/A) |
13.94 (11.03) |
-20.88% | Details | |
| 5/6/2026 | OnKure Therapeutics Inc. | OKUR | Downgrade | Hold (Buy) |
4.52 (2.10) |
-53.54% | Details | |
| 4/28/2026 | Janux Therapeutics | JANX | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2026 | Whitehawk Therapeutics | WHWK | New Coverage | Buy (N/A) |
3.51 (2.89) |
-17.66% | Details | |
| 4/6/2026 | Protara Therapeutics | TARA | New Coverage | Buy (N/A) |
5.11 (2.32) |
-54.6% | Details | |
| 4/6/2026 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
3.32 (3.47) |
4.52% | Details | |
| 4/6/2026 | ORIC Pharmaceuticals | ORIC | New Coverage | Buy (N/A) |
8.89 (12.35) |
38.92% | Details | |
| 4/6/2026 | OnKure Therapeutics Inc. | OKUR | New Coverage | Buy (N/A) |
4.29 (4.52) |
5.36% | Details | |
| 4/6/2026 | Oncolytics Biotech | ONCY | New Coverage | Hold (N/A) |
0.96 (0.50) |
-47.92% | Details | |
| 4/6/2026 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
4.41 (4.45) |
0.91% | Details | |
| 4/6/2026 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
55.13 (69.27) |
25.65% | Details | |
| 4/6/2026 | Janux Therapeutics | JANX | New Coverage | Buy (N/A) |
14.84 (16.51) |
11.25% | Details | |
| 4/6/2026 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.44 (1.11) |
-22.92% | Details | |
| 4/6/2026 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
38.83 (37.32) |
-3.89% | Details | |
| 4/6/2026 | Elicio Therapeutics | ELTX | New Coverage | Buy (N/A) |
10.65 (14.85) |
39.44% | Details | |
| 4/6/2026 | Editas Medicine | EDIT | New Coverage | Buy (N/A) |
2.67 (2.35) |
-11.99% | Details | |
| 4/6/2026 | Day One Biopharmaceuticals | DAWN | New Coverage | Hold (N/A) |
21.45 (21.53) |
0.37% | Details | |
| 4/6/2026 | Curis | CRIS | New Coverage | Buy (N/A) |
0.55 (0.41) |
-25.45% | Details | |
| 4/6/2026 | Cullinan Oncology Inc. | CGEM | New Coverage | Buy (N/A) |
14.43 (12.93) |
-10.4% | Details | |
| 4/6/2026 | Context Therapeutics | CNTX | New Coverage | Buy (N/A) |
2.72 (0.24) |
-91.18% | Details | |
| 4/6/2026 | CG Oncology | CGON | New Coverage | Buy (N/A) |
67.48 (59.85) |
-11.31% | Details | |
| 4/6/2026 | CervoMed | CRVO | New Coverage | Buy (N/A) |
4.14 (2.24) |
-45.89% | Details | |
| 4/6/2026 | Bolt Biotherapeutics, Inc. | BOLT | New Coverage | Hold (N/A) |
4.29 (4.00) |
-6.76% | Details | |
| 4/6/2026 | Bicara Therapeutics Inc | BCAX | New Coverage | Buy (N/A) |
21.47 (16.78) |
-21.84% | Details | |
| 4/6/2026 | Beam Therapeutics Inc | BEAM | New Coverage | Buy (N/A) |
24.66 (23.47) |
-4.83% | Details | |
| 4/6/2026 | aTyr Pharma | ATYR | New Coverage | Hold (N/A) |
0.85 (0.17) |
-80% | Details | |
| 4/6/2026 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
24.89 (16.66) |
-33.07% | Details | |
| 4/6/2026 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
6.99 (4.57) |
-34.62% | Details |
